Collegium announces eight poster presentations at the 2024 PAINWeek conference

STOUGHTON, Mass., Aug. 28, 2024 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading diversified pharmaceutical company committed to improving the lives of people with serious medical conditions, today announced eight poster presentations will be presented at the 2024 PAINWeek Conference, taking place September 3-6, 2024 in Las Vegas, Nevada.

“Collegium is proud to showcase new real-world data at PAINWeek 2024 as part of our commitment to leading the way with science and responsible pain management,” said Thomas Smith, MD, Chief Medical Officer of Collegium. “The eight posters demonstrate the clinical and population health impact of our meaningfully differentiated pain portfolio and provide important insights for healthcare decision makers who treat people in pain. We welcome opportunities to share clinical and real-world data with the medical community as we continue our mission to improve the lives of people with serious medical conditions.”